CD276 and glioblastoma: In addition, epidermal growth factor (EGF) receptor variant III (EGFRvIII), human EGF receptor 2 (HER2), interleukin-13 receptor α2 chain (IL13Rα2), and B7-H3 have been used as target antigens for CAR-T cell therapy for GBM [7, 10–14].